Skip to main content

Table 1 General inclusion and exclusion criteria

From: Intravenous immunoglobulin in the treatment of primary trigeminal neuralgia refractory to carbamazepine: a study protocol[ISRCTN33042138]

Inclusion criteria

Primary idiopathic trigeminal neuralgia

Age over 18

Insufficient benefit from carbamazepine therapy

Exclusion criteria

Serum IgA less than half normal value

Pregnancy or breastfeeding mothers

Progressive renal failure

Bedridden patients

Any disorder requiring treatment with IVIG